SCM
ICPT
Sarissa Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-950
| Closed | -$18K | – | 13 |
|
|
2021
Q2 | $18K | Hold |
950
| – | – | ﹤0.01% | 14 |
|
|
2021
Q1 | $21K | Hold |
950
| – | – | ﹤0.01% | 14 |
|
|
2020
Q4 | $23K | Sell |
950
-1,200,050
| -100% | -$29.1M | ﹤0.01% | 12 |
|
|
2020
Q3 | $49.8M | Hold |
1,201,000
| – | – | 5.86% | 8 |
|
|
2020
Q2 | $57.5M | Buy |
1,201,000
+46,000
| +4% | +$2.2M | 6.4% | 8 |
|
|
2020
Q1 | $72.7M | Buy |
1,155,000
+295,000
| +34% | +$18.6M | 9.28% | 7 |
|
|
2019
Q4 | $107M | Buy |
860,000
+9,000
| +1% | +$1.12M | 8.85% | 4 |
|
|
2019
Q3 | $56.5M | Buy |
851,000
+94,000
| +12% | +$6.24M | 7.08% | 6 |
|
|
2019
Q2 | $60.2M | Buy |
757,000
+437,000
| +137% | +$34.8M | 7.51% | 6 |
|
|
2019
Q1 | $35.8M | Buy |
320,000
+266,000
| +493% | +$29.8M | 5.39% | 7 |
|
|
2018
Q4 | $5.44M | Sell |
54,000
-203,500
| -79% | -$20.5M | 1.21% | 7 |
|
|
2018
Q3 | $32.5M | Sell |
257,500
-377,800
| -59% | -$47.7M | 7.18% | 6 |
|
|
2018
Q2 | $53.3M | Hold |
635,300
| – | – | 10.69% | 6 |
|
|
2018
Q1 | $39.1M | Buy |
635,300
+453,000
| +248% | +$27.9M | 9.04% | 7 |
|
|
2017
Q4 | $10.6M | Buy |
+182,300
| New | +$10.6M | 2.73% | 7 |
|